YTENQ — Yield10 Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Yield10 Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11.1	9.7	16	4.35	1.07
Net Total Accounts Receivable
Net Total Receivables	0.092	0.113	0.198	0.03	0
Prepaid Expenses
Total Current Assets	11.7	10.3	16.6	5.02	1.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.38	3.63	3.24	2.74	2.2
Other Long Term Assets
Total Assets	16.7	14.5	20.4	8.09	3.91
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	2.21	1.81	1.73	1.61	4.87
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	20.8	4.99	4.39	3.69	6.39
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-4.08	9.53	16	4.4	-2.48
Total Liabilities & Shareholders' Equity	16.7	14.5	20.4	8.09	3.91
Total Common Shares Outstanding
Total Preferred Shares Outstanding